Emregul, E., David, A., & Balthasar, J. P. (2005). A GPIIb/IIIa bioreactor for specific treatment of immune thrombocytopenic purpura, an autoimmune disease. Preparation, in vitro characterization, and preliminary proof-of-concept animal studies. Journal of Biomedical Materials Research, 75A(3), 648. https://doi.org/10.1002/jbm.a.30470
Chicago Style (17th ed.) CitationEmregul, Emel, Allan David, and Joseph P. Balthasar. "A GPIIb/IIIa Bioreactor for Specific Treatment of Immune Thrombocytopenic Purpura, an Autoimmune Disease. Preparation, in Vitro Characterization, and Preliminary Proof-of-concept Animal Studies." Journal of Biomedical Materials Research 75A, no. 3 (2005): 648. https://doi.org/10.1002/jbm.a.30470.
MLA (9th ed.) CitationEmregul, Emel, et al. "A GPIIb/IIIa Bioreactor for Specific Treatment of Immune Thrombocytopenic Purpura, an Autoimmune Disease. Preparation, in Vitro Characterization, and Preliminary Proof-of-concept Animal Studies." Journal of Biomedical Materials Research, vol. 75A, no. 3, 2005, p. 648, https://doi.org/10.1002/jbm.a.30470.